Metabolic reprogramming in skeletal cell differentiation

Abstract

The human skeleton is a multifunctional organ made up of multiple cell types working in concert to maintain bone and mineral homeostasis and to perform critical mechanical and endocrine functions. From the beginning steps of chondrogenesis that prefigures most of the skeleton, to the rapid bone accrual during skeletal growth, followed by bone remodeling of the mature skeleton, cell differentiation is integral to skeletal health. While growth factors and nuclear proteins that influence skeletal cell differentiation have been extensively studied, the role of cellular metabolism is just beginning to be uncovered. Besides energy production, metabolic pathways have been shown to exert epigenetic regulation via key metabolites to influence cell fate in both cancerous and normal tissues. In this review, we will assess the role of growth factors and transcription factors in reprogramming cellular metabolism to meet the energetic and biosynthetic needs of chondrocytes, osteoblasts, or osteoclasts. We will also summarize the emerging evidence linking metabolic changes to epigenetic modifications during skeletal cell differentiation.

References

[1.] WeberDR, HaynesK, LeonardMB, WilliSM, DenburgMR. Type 1 Diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using the health improvement network (THIN). Diabetes Care, 2015, 38: 1913-1920

[2.] SellmeyerDE, et al. . Skeletal metabolism, fracture risk, and fracture outcomes in Type 1 and Type 2 Diabetes. Diabetes, 2016, 65: 1757-1766

[3.] FerrariSL, et al. . Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos. Int., 2018, 29: 2585-2596

[4.] JanghorbaniM, FeskanichD, WillettWC, HuF. Prospective study of diabetes and risk of hip fracture: the nurses’ health study. Diabetes Care, 2006, 29: 1573-1578

[5.] WeberDR, LongF, ZemelBS, KindlerJM. Glycemic control and bone in diabetes. Curr. Osteoporos. Rep., 2022, 20: 379-388

[6.] Lee, W. C., Guntur, A. R., Long, F. & Rosen, C. J. Energy metabolism of the osteoblast: implications for osteoporosis. Endocr. Rev. 38, 255–266 (2017).

[7.] SchettG, et al. . Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care, 2013, 36: 403-409

[8.] FelsonDT, et al. . Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann. Intern. Med., 2000, 133: 635-646

[9.] Forte, Y. S., Renovato-Martins, M. & Barja-Fidalgo, C. Cellular and molecular mechanisms associating obesity to bone loss. Cells12, 521 (2023).

[10.] SongY, LiuJ, ZhaoK, GaoL, ZhaoJ. Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases. Cell Metab., 2021, 33: 1911-1925

[11.] AugustinR. The protein family of glucose transport facilitators: it’s not only about glucose after all. IUBMB Life, 2010, 62: 315-333

[12.] LongF. Glucose metabolism in skeletal cells. Bone Rep., 2022, 17

[13.] SchieberM, ChandelNS. ROS function in redox signaling and oxidative stress. Curr. Biol., 2014, 24: R453-R462

[14.] WarburgO, PosenerK, NegeleinE. The metabolism of cancer cells. Biochem. Z., 1924, 152: 319-344

[15.] WarburgO. On the origin of cancer cells. Science, 1956, 123: 309-314

[16.] Vander HeidenMG, CantleyLC, ThompsonCB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 2009, 324: 1029-1033

[17.] DevignesCS, CarmelietG, StegenS. Amino acid metabolism in skeletal cells. Bone Rep., 2022, 17

[18.] ChandelNS. Amino acid metabolism. Cold Spring Harb. Perspect. Biol., 2021, 13: a040584

[19.] HoutenSM, ViolanteS, VenturaFV, WandersRJA. The biochemistry and physiology of mitochondrial fatty Acid β-Oxidation and its genetic disorders. Annu. Rev. Physiol., 2016, 78: 23-44

[20.] SharmaU, RandoOJ. Metabolic inputs into the epigenome. Cell Metab., 2017, 25: 544-558

[21.] HuoM, ZhangJ, HuangW, WangY. Interplay among metabolism, epigenetic modifications, and gene expression in cancer. Front. Cell Dev. Biol., 2021, 9: 793428

[22.] Paro R., et al. in Introduction to Epigenetics (Springer, 2021).

[23.] SebastianC, VongJSL, MayekarMK, TummalaKS, SinghI. Editorial: metabolism and epigenetics. Front. Genet., 2022, 13: 877538

[24.] ZhangD, et al. . Metabolic regulation of gene expression by histone lactylation. Nature, 2019, 574: 575-580

[25.] YuJ, et al. . Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma. Genome Biol., 2021, 22: 1-21

[26.] JiangJ, et al. . Lactate modulates cellular metabolism through histone lactylation-mediated gene expression in non-small cell lung cancer. Front. Oncol., 2021, 11

[27.] Lin, X. et al. Augmentation of scleral glycolysis promotes myopia through histone lactylation. Cell Metab.36, 511–525 (2024).

[28.] LongF, OrnitzDM. Development of the endochondral skeleton. Cold Spring Harb. Perspect. Biol., 2013, 5: a008334

[29.] AkiyamaH. Control of chondrogenesis by the transcription factor Sox9. Mod. Rheumatol., 2008, 18: 213-219

[30.] AmarilioR, et al. . HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development, 2007, 134: 3917-3928

[31.] BarnaM, NiswanderL. Visualization of cartilage formation: insight into cellular properties of skeletal progenitors and chondrodysplasia syndromes. Dev. Cell, 2007, 12: 931-941

[32.] LimJ, et al. . BMP-Smad4 signaling is required for precartilaginous mesenchymal condensation independent of Sox9 in the mouse. Dev. Biol., 2015, 400: 132-138

[33.] AkiyamaH, ChaboissierMC, MartinJF, SchedlA, de CrombruggheB. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev., 2002, 16: 2813-2828

[34.] SmitsP, et al. . The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev. Cell, 2001, 1: 277-290

[35.] YangL, TsangKY, TangHC, ChanD, CheahKS. Hypertrophic chondrocytes can become osteoblasts and osteocytes in endochondral bone formation. Proc. Natl. Acad. Sci. USA, 2014, 111: 12097-12102

[36.] ZhouX, et al. . Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice. PLoS Genet., 2014, 10: e1004820

[37.] QinX, et al. . Runx2 is essential for the transdifferentiation of chondrocytes into osteoblasts. PLoS Genet., 2020, 16: e1009169

[38.] ParkJ, et al. . Dual pathways to endochondral osteoblasts: a novel chondrocyte-derived osteoprogenitor cell identified in hypertrophic cartilage. Biol. Open, 2015, 4: 608-621

[39.] MurakamiS, KanM, McKeehanWL, de CrombruggheB. Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA, 2000, 97: 1113-1118

[40.] RettingKN, SongB, YoonBS, LyonsKM. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development, 2009, 136: 1093-1104

[41.] YoonBS, et al. . Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc. Natl. Acad. Sci. USA, 2005, 102: 5062-5067

[42.] SeoHS, SerraR. Deletion of Tgfbr2 in Prx1-cre expressing mesenchyme results in defects in development of the long bones and joints. Dev. Biol., 2007, 310: 304-316

[43.] SpagnoliA, et al. . TGF-beta signaling is essential for joint morphogenesis. J. Cell Biol., 2007, 177: 1105-1117

[44.] GoldringMB, TsuchimochiK, IjiriK. The control of chondrogenesis. J. Cell Biochem., 2006, 97: 33-44

[45.] St-JacquesB, HammerschmidtM, McMahonAP. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev., 1999, 13: 2072-2086

[46.] VortkampA, et al. . Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science, 1996, 273: 613-622

[47.] BakerJ, LiuJP, RobertsonEJ, EfstratiadisA. Role of insulin-like growth factors in embryonic and postnatal growth. Cell, 1993, 75: 73-82

[48.] LongF, JoengKS, XuanS, EfstratiadisA, McMahonAP. Independent regulation of skeletal growth by Ihh and IGF signaling. Dev. Biol., 2006, 298: 327-333

[49.] BegemannM, et al. . Paternally inherited IGF2 mutation and growth restriction. N. Engl. J. Med., 2015, 373: 349-356

[50.] UchimuraT, et al. . An essential role for IGF2 in cartilage development and glucose metabolism during postnatal long bone growth. Development, 2017, 144: 3533-3546

[51.] PerbalB. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol. Pathol., 2001, 54: 57-79

[52.] IvkovicS, et al. . Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development, 2003, 130: 2779-2791

[53.] KawakiH, et al. . Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage. J. Bone Miner. Res., 2008, 23: 1751-1764

[54.] UsamiY, GunawardenaAT, IwamotoM, Enomoto-IwamotoM. Wnt signaling in cartilage development and diseases: lessons from animal studies. Lab Investig., 2016, 96: 186-196

[55.] ChurchV, NohnoT, LinkerC, MarcelleC, Francis-WestP. Wnt regulation of chondrocyte differentiation. J. Cell Sci., 2002, 115: 4809-4818

[56.] HartmannC, TabinCJ. Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development, 2000, 127: 3141-3159

[57.] HillTP, SpaterD, TaketoMM, BirchmeierW, HartmannC. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell, 2005, 8: 727-738

[58.] DayTF, GuoX, Garrett-BealL, YangY. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell, 2005, 8: 739-750

[59.] AkiyamaH, et al. . Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev., 2004, 18: 1072-1087

[60.] DongY, et al. . RBPjkappa-dependent Notch signaling regulates mesenchymal progenitor cell proliferation and differentiation during skeletal development. Development, 2010, 137: 1461-1471

[61.] ChenS, et al. . Notch gain of function inhibits chondrocyte differentiation via Rbpj-dependent suppression of Sox9. J. Bone Miner. Res., 2013, 28: 649-659

[62.] KohnA, et al. . Cartilage-specific RBPjkappa-dependent and -independent Notch signals regulate cartilage and bone development. Development, 2012, 139: 1198-1212

[63.] LeeSY, AbelED, LongF. Glucose metabolism induced by Bmp signaling is essential for murine skeletal development. Nat. Commun., 2018, 9

[64.] StegenS, et al. . De novo serine synthesis regulates chondrocyte proliferation during bone development and repair. Bone Res., 2022, 10: 14

[65.] MobasheriA, NeamaG, BellS, RichardsonS, CarterSD. Human articular chondrocytes express three facilitative glucose transporter isoforms: GLUT1, GLUT3 and GLUT9. Cell Biol. Int., 2002, 26: 297-300

[66.] ShikhmanAR, BrinsonDC, ValbrachtJ, LotzMK. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J. Immunol., 2001, 167: 7001-7008

[67.] ShikhmanAR, BrinsonDC, LotzMK. Distinct pathways regulate facilitated glucose transport in human articular chondrocytes during anabolic and catabolic responses. Am. J. Physiol. Endocrinol. Metab., 2004, 286: E980-E985

[68.] LiK, et al. . Impaired glucose metabolism underlies articular cartilage degeneration in osteoarthritis. FASEB J., 2022, 36

[69.] WangC, et al. . Deletion of Glut1 in early postnatal cartilage reprograms chondrocytes toward enhanced glutamine oxidation. Bone Res., 2021, 9: 38

[70.] SemenzaGL. Hypoxia-inducible factors in physiology and medicine. Cell, 2012, 148: 399-408

[71.] KimJW, TchernyshyovI, SemenzaGL, DangCV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab., 2006, 3: 177-185

[72.] PapandreouI, CairnsRA, FontanaL, LimAL, DenkoNC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab., 2006, 3: 187-197

[73.] SchipaniE, et al. . Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev., 2001, 15: 2865-2876

[74.] YaoQ, et al. . Suppressing mitochondrial respiration is critical for hypoxia tolerance in the fetal growth plate. Dev. Cell, 2019, 49: 748-763.e747

[75.] StegenS, et al. . HIF-1alpha metabolically controls collagen synthesis and modification in chondrocytes. Nature, 2019, 565: 511-515

[76.] KosaiA, et al. . Changes in acetyl-CoA mediate Sik3-induced maturation of chondrocytes in endochondral bone formation. Biochem. Biophys. Res. Commun., 2019, 516: 1097-1102

[77.] HollanderJM, et al. . A critical bioenergetic switch is regulated by IGF2 during murine cartilage development. Commun. Biol., 2022, 5: 1230

[78.] de Paz-LugoP, LupianezJA, Melendez-HeviaE. High glycine concentration increases collagen synthesis by articular chondrocytes in vitro: acute glycine deficiency could be an important cause of osteoarthritis. Amino Acids, 2018, 50: 1357-1365

[79.] KimMS, et al. . Leucine restriction inhibits chondrocyte proliferation and differentiation through mechanisms both dependent and independent of mTOR signaling. Am. J. Physiol. Endocrinol. Metab., 2009, 296: E1374-E1382

[80.] HandleyCJ, SpeightG, LeydenKM, LowtherDA. Extracellular matrix metabolism by chondrocytes. 7. Evidence that L-glutamine is an essential amino acid for chondrocytes and other connective tissue cells. Biochim. Biophys. Acta, 1980, 627: 324-331

[81.] StegenS, et al. . Glutamine metabolism controls chondrocyte identity and function. Dev. Cell, 2020, 53: 530-544.e538

[82.] van GastelN, et al. . Lipid availability determines fate of skeletal progenitor cells via SOX9. Nature, 2020, 579: 111-117

[83.] WangC, SilvermanRM, ShenJ, O’KeefeRJ. Distinct metabolic programs induced by TGF-beta1 and BMP2 in human articular chondrocytes with osteoarthritis. J. Orthop. Transl., 2018, 12: 66-73

[84.] Maeda-UematsuA, et al. . CCN2 as a novel molecule supporting energy metabolism of chondrocytes. J. Cell Biochem., 2014, 115: 854-865

[85.] MuraseY, et al. . Role of CCN2 in amino acid metabolism of chondrocytes. J. Cell Biochem., 2016, 117: 927-937

[86.] LongF. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol., 2012, 13: 27-38

[87.] AkiyamaH, et al. . Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc. Natl. Acad. Sci. USA, 2005, 102: 14665-14670

[88.] DucyP, ZhangR, GeoffroyV, RidallAL, KarsentyG. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell, 1997, 89: 747-754

[89.] KomoriT, et al. . Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 1997, 89: 755-764

[90.] LongF. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol., 2011, 13: 27-38

[91.] YangX, et al. . ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell, 2004, 117: 387-398

[92.] NakashimaK, et al. . The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell, 2002, 108: 17-29

[93.] RoblingAG, BonewaldLF. The osteocyte: new insights. Annu. Rev. Physiol., 2020, 82: 485-506

[94.] LongF, et al. . Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development, 2004, 131: 1309-1318

[95.] JoengKS, LongF. The Gli2 transcriptional activator is a crucial effector for Ihh signaling in osteoblast development and cartilage vascularization. Development, 2009, 136: 4177-4185

[96.] HiltonMJ, TuX, CookJ, HuH, LongF. Ihh controls cartilage development by antagonizing Gli3, but requires additional effectors to regulate osteoblast and vascular development. Development, 2005, 132: 4339-4351

[97.] TuX, JoengKS, LongF. Indian hedgehog requires additional effectors besides Runx2 to induce osteoblast differentiation. Dev. Biol., 2012, 362: 76-82

[98.] ShiY, et al. . Gli1 identifies osteogenic progenitors for bone formation and fracture repair. Nat. Commun., 2017, 8

[99.] BandyopadhyayA, et al. . Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet., 2006, 2: e216

[100.] LimJ, et al. . Dual function of Bmpr1a signaling in restricting preosteoblast proliferation and stimulating osteoblast activity in mouse. Development, 2016, 143: 339-347

[101.] Karner, C. M., Lee, S. Y. & Long, F. Bmp induces osteoblast differentiation through both Smad4 and mTORC1 Signaling. Mol. Cell Biol.37, e00253-16 (2017).

[102.] KamiyaN, et al. . Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J. Bone Miner. Res., 2008, 23: 2007-2017

[103.] KamiyaN, et al. . BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development, 2008, 135: 3801-3811

[104.] HeG, et al. . Differential involvement of Wnt signaling in Bmp regulation of cancellous versus periosteal bone growth. Bone Res., 2017, 5

[105.] KamiyaN, KaartinenVM, MishinaY. Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1. Biochem. Biophys. Res. Commun., 2011, 414: 326-330

[106.] KamiyaN, et al. . Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J. Bone Miner. Res., 2010, 25: 200-210

[107.] LoweryJW, et al. . Loss of BMPR2 leads to high bone mass due to increased osteoblast activity. J. Cell Sci., 2015, 128: 1308-1315

[108.] MaupinKA, DroschaCJ, WilliamsBO. A comprehensive overview of skeletal phenotypes associatred with alterations in Wnt/b-catenin signaling in humans and mice. Bone Res., 2013, 1: 27-71

[109.] HuH, et al. . Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development, 2005, 132: 49-60

[110.] RoddaSJ, McMahonAP. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development, 2006, 133: 3231-3244

[111.] JoengKS, SchumacherCA, Zylstra-DiegelCR, LongF, WilliamsBO. Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo. Dev. Biol., 2011, 359: 222-229

[112.] TuX, et al. . Noncanonical Wnt A signaling through G Protein-Linked PKCdelta activation promotes bone formation. Dev. Cell, 2007, 12: 113-127

[113.] ChenJ, et al. . WNT7B promotes bone formation in part through mTORC1. PLoS Genet., 2014, 10: e1004145

[114.] JoengKS, et al. . Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis. J. Clin. Investig., 2017, 127: 2678-2688

[115.] OrnitzDM, MariePJ. Fibroblast growth factors in skeletal development. Curr. Top. Dev. Biol., 2019, 133: 195-234

[116.] MonteroA, et al. . Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Investig., 2000, 105: 1085-1093

[117.] LiuZ, XuJ, ColvinJS, OrnitzDM. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev., 2002, 16: 859-869

[118.] YuK, et al. . Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development, 2003, 130: 3063-3074

[119.] JacobAL, SmithC, PartanenJ, OrnitzDM. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev. Biol., 2006, 296: 315-328

[120.] Valverde-FrancoG, et al. . Defective bone mineralization and osteopenia in young adult FGFR3-/- mice. Hum. Mol. Genet., 2004, 13: 271-284

[121.] McKenzieJ, et al. . Osteocyte death and bone overgrowth in mice lacking fibroblast growth factor receptors 1 and 2 in Mature Osteoblasts and Osteocytes. J. Bone Miner. Res., 2019, 34: 1660-1675

[122.] HiltonMJ, et al. . Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat. Med., 2008, 14: 306-314

[123.] TuX, et al. . Physiological notch signaling maintains bone homeostasis via RBPjk and Hey upstream of NFATc1. PLoS Genet., 2012, 8: e1002577

[124.] ZanottiS, et al. . Notch inhibits osteoblast differentiation and causes osteopenia. Endocrinology, 2008, 149: 3890-3899

[125.] EnginF, et al. . Dimorphic effects of Notch signaling in bone homeostasis. Nat. Med., 2008, 14: 299-305

[126.] EnginF, et al. . Notch signaling contributes to the pathogenesis of human osteosarcomas. Hum. Mol. Genet., 2009, 18: 1464-1470

[127.] CohnDV, ForscherBK. Aerobic metabolism of glucose by bone. J. Biol. Chem., 1962, 237: 615-618

[128.] PeckWA, BirgeSJJr., FedakSA. Bone cells: biochemical and biological studies after enzymatic isolation. Science, 1964, 146: 1476-1477

[129.] BorleAB, NicholsN, NicholsGJr.. Metabolic studies of bone in vitro. I. Normal bone. J. Biol. Chem., 1960, 235: 1206-1210

[130.] NeumanWF, NeumanMW, BrommageR. Aerobic glycolysis in bone: lactate production and gradients in calvaria. Am. J. Physiol., 1978, 234: C41-C50

[131.] FelixR, NeumanWF, FleischH. Aerobic glycolysis in bone: lactic acid production by rat calvaria cells in culture. Am. J. Physiol., 1978, 234: C51-C55

[132.] LeeWC, JiX, NissimI, LongF. Malic enzyme couples mitochondria with aerobic glycolysis in osteoblasts. Cell Rep., 2020, 32

[133.] LehningerAL. Mitochondria and biological mineralization processes: an exploration. Horiz. Biochem. Biophys., 1977, 4: 1-30

[134.] BoonrungsimanS, et al. . The role of intracellular calcium phosphate in osteoblast-mediated bone apatite formation. Proc. Natl. Acad. Sci. USA, 2012, 109: 14170-14175

[135.] DixonTF, PerkinsHR. Citric acid and bone metabolism. Biochem. J., 1952, 52: 260-265

[136.] TaylorTG. The nature of bone citrate. Biochim. Biophys. Acta, 1960, 39: 148-149

[137.] Costello, L. C., Franklin, R. B., Reynolds, M. A. & Chellaiah, M. The important role of osteoblasts and citrate production in bone formation: “osteoblast citration” as a new concept for an old relationship. Open Bone J.4, https://doi.org/10.2174/1876525401204010027 (2012).

[138.] DirckxN, MoorerMC, ClemensTL, RiddleRC. The role of osteoblasts in energy homeostasis. Nat. Rev. Endocrinol., 2019, 15: 651-665

[139.] DirckxN, et al. . A specialized metabolic pathway partitions citrate in hydroxyapatite to impact mineralization of bones and teeth. Proc. Natl. Acad. Sci. USA, 2022, 119

[140.] WeiJ, et al. . Glucose uptake and Runx2 synergize to orchestrate osteoblast differentiation and bone formation. Cell, 2015, 161: 1576-1591

[141.] SchajowiczF, CabriniRL. Histochemical studies on glycogen in normal ossification and calcification. J. Bone Jt. Surg. Am., 1958, 40-A: 1081-1092

[142.] ChevalleyT, RizzoliR, ManenD, CaverzasioJ, BonjourJP. Arginine increases insulin-like growth factor-I production and collagen synthesis in osteoblast-like cells. Bone, 1998, 23: 103-109

[143.] JinZ, et al. . Nitric oxide modulates bone anabolism through regulation of osteoblast glycolysis and differentiation. J. Clin. Investig., 2021, 131: e138935

[144.] BrownPM, HutchisonJD, CrockettJC. Absence of glutamine supplementation prevents differentiation of murine calvarial osteoblasts to a mineralizing phenotype. Calcif. Tissue Int., 2011, 89: 472-482

[145.] KarnerCM, EsenE, OkunadeAL, PattersonBW, LongF. Increased glutamine catabolism mediates bone anabolism in response to WNT signaling. J. Clin. Investig., 2015, 125: 551-562

[146.] StegenS, et al. . HIF-1α promotes glutamine-mediated redox homeostasis and glycogen-dependent bioenergetics to support postimplantation bone cell survival. Cell Metab., 2016, 23: 265-279

[147.] ShenL, SharmaD, YuY, LongF, KarnerCM. Biphasic regulation of glutamine consumption by WNT during osteoblast differentiation. J. Cell Sci., 2021, 134: jcs251645

[148.] SharmaD, YuY, ShenL, ZhangGF, KarnerCM. SLC1A5 provides glutamine and asparagine necessary for bone development in mice. Elife, 2021, 10: e71595

[149.] ShenL, YuY, KarnerCM. SLC38A2 provides proline and alanine to regulate postnatal bone mass accrual in mice. Front. Physiol., 2022, 13

[150.] BarteltA, et al. . Quantification of bone fatty acid metabolism and its regulation by adipocyte lipoprotein lipase. Int. J. Mol. Sci., 2017, 18: 1264

[151.] KimSP, et al. . Fatty acid oxidation by the osteoblast is required for normal bone acquisition in a sex- and diet-dependent manner. JCI Insight, 2017, 2: e92704

[152.] NiemeierA, et al. . Uptake of postprandial lipoproteins into bone in vivo: impact on osteoblast function. Bone, 2008, 43: 230-237

[153.] ReganJN, et al. . Up-regulation of glycolytic metabolism is required for HIF1alpha-driven bone formation. Proc. Natl. Acad. Sci. USA, 2014, 111: 8673-8678

[154.] KarnerCM, LongF. Wnt signaling and cellular metabolism in osteoblasts. Cell Mol. Life Sci., 2017, 74: 1649-1657

[155.] EsenE, et al. . WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation. Cell Metab., 2013, 17: 745-755

[156.] Chen, J., Holguin, N., Shi, Y., Silva, M. J. & Long, F. mTORC2 signaling promotes skeletal growth and bone formation in mice. J. Bone Miner. Res.30, 369–378 (2014).

[157.] SunW, ShiY, LeeWC, LeeSY, LongF. Rictor is required for optimal bone accrual in response to anti-sclerostin therapy in the mouse. Bone, 2016, 85: 1-8

[158.] ChenH, et al. . Increased glycolysis mediates Wnt7b-induced bone formation. FASEB J., 2019, 33: 7810-7821

[159.] YangYY, et al. . Lgr4 promotes aerobic glycolysis and differentiation in osteoblasts via the canonical Wnt/beta-catenin pathway. J. Bone Miner. Res., 2021, 36: 1605-1620

[160.] CarmonKS, GongX, LinQ, ThomasA, LiuQ. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc. Natl. Acad. Sci. USA, 2011, 108: 11452-11457

[161.] KarnerCM, et al. . Wnt protein signaling reduces nuclear Acetyl-CoA levels to suppress gene expression during osteoblast differentiation. J. Biol. Chem., 2016, 291: 13028-13039

[162.] FreyJL, et al. . Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast. Mol. Cell Biol., 2015, 35: 1979-1991

[163.] EsenE, LeeSY, WiceBM, LongF. PTH promotes bone anabolism by stimulating aerobic glycolysis via IGF signaling. J. Bone Miner. Res., 2015, 30: 1959-1968

[164.] StegenS, et al. . Glutamine metabolism in osteoprogenitors is required for bone mass accrual and PTH-induced bone anabolism in male mice. J. Bone Miner. Res., 2021, 36: 604-616

[165.] ReganJ, LongF. Notch signaling and bone remodeling. Curr. Osteoporos. Rep., 2013, 11: 126-129

[166.] LeeSY, LongF. Notch signaling suppresses glucose metabolism in mesenchymal progenitors to restrict osteoblast differentiation. J. Clin. Investig., 2018, 128: 5573-5586

[167.] LiuZ, et al. . Mitochondrial function is compromised in cortical bone osteocytes of long-lived growth hormone receptor null mice. J. Bone Miner. Res., 2019, 34: 106-122

[168.] NianF, et al. . LDHA promotes osteoblast differentiation through histone lactylation. Biochem. Biophys. Res. Commun., 2022, 615: 31-35

[169.] MinamiE, et al. . Lactate-induced histone lactylation by p300 promotes osteoblast differentiation. PLoS One, 2023, 18: e0293676

[170.] WuJ, et al. . Endothelial cell-derived lactate triggers bone mesenchymal stem cell histone lactylation to attenuate osteoporosis. Adv. Science, 2023, 10

[171.] TournaireG, et al. . Skeletal progenitors preserve proliferation and self-renewal upon inhibition of mitochondrial respiration by rerouting the TCA cycle. Cell Rep., 2022, 40

[172.] VeisDJ, O’BrienCA. Osteoclasts, master sculptors of bone. Annu. Rev. Pathol., 2023, 18: 257-281

[173.] TeitelbaumSL, RossFP. Genetic regulation of osteoclast development and function. Nat. Rev. Genet., 2003, 4: 638-649

[174.] KurotakiD, YoshidaH, TamuraT. Epigenetic and transcriptional regulation of osteoclast differentiation. Bone, 2020, 138

[175.] ChenW, et al. . C/EBPalpha regulates osteoclast lineage commitment. Proc. Natl. Acad. Sci. USA, 2013, 110: 7294-7299

[176.] TakayanagiH, et al. . Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell, 2002, 3: 889-901

[177.] ParkJH, LeeNK, LeeSY. Current understanding of RANK signaling in osteoclast differentiation and maturation. Mol. Cells, 2017, 40: 706-713

[178.] Park-MinKH, et al. . Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation. Nat. Commun., 2014, 5

[179.] HumphreyMB, NakamuraMC. A comprehensive review of immunoreceptor regulation of osteoclasts. Clin. Rev. Allergy Immunol., 2016, 51: 48-58

[180.] ZhaoB, et al. . Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat. Med., 2009, 15: 1066-1071

[181.] KimK, et al. . MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood, 2007, 109: 3253-3259

[182.] NishikawaK, et al. . Blimp1-mediated repression of negative regulators is required for osteoclast differentiation. Proc. Natl. Acad. Sci. USA, 2010, 107: 3117-3122

[183.] LiS, et al. . RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis. J. Clin. Investig., 2014, 124: 5057-5073

[184.] MunSH, ParkPSU, Park-MinKH. The M-CSF receptor in osteoclasts and beyond. Exp. Mol. Med., 2020, 52: 1239-1254

[185.] MbalavieleG, NovackDV, SchettG, TeitelbaumSL. Inflammatory osteolysis: a conspiracy against bone. J. Clin. Investig., 2017, 127: 2030-2039

[186.] XiongJ, et al. . Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss. Nat. Commun., 2018, 9

[187.] AsanoT, et al. . Soluble RANKL is physiologically dispensable but accelerates tumour metastasis to bone. Nat. Metab., 2019, 1: 868-875

[188.] XiongJ, et al. . Matrix-embedded cells control osteoclast formation. Nat. Med., 2011, 17: 1235-1241

[189.] NakashimaT, et al. . Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med., 2011, 17: 1231-1234

[190.] YuW, et al. . Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss. J. Clin. Investig, 2021, 131: e140214

[191.] HuY, et al. . RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss. EMBO Rep., 2021, 22

[192.] TsukasakiM, et al. . OPG production matters where it happened. Cell Rep., 2020, 32

[193.] CawleyKM, et al. . Local production of osteoprotegerin by osteoblasts suppresses bone resorption. Cell Rep., 2020, 32

[194.] GlantschnigH, FisherJE, WesolowskiG, RodanGA, ReszkaAA. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death Differ., 2003, 10: 1165-1177

[195.] TiedemannK, et al. . Regulation of osteoclast growth and fusion by mTOR/raptor and mTOR/rictor/Akt. Front. Cell Dev. Biol., 2017, 5: 54

[196.] LemmaS, et al. . Energy metabolism in osteoclast formation and activity. Int. J. Biochem. Cell Biol., 2016, 79: 168-180

[197.] LiB, et al. . Both aerobic glycolysis and mitochondrial respiration are required for osteoclast differentiation. FASEB J., 2020, 34: 11058-11067

[198.] IshiiKA, et al. . Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat. Med., 2009, 15: 259-266

[199.] JinZ, WeiW, YangM, DuY, WanY. Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell Metab., 2014, 20: 483-498

[200.] MiyazakiT, et al. . Intracellular and extracellular ATP coordinately regulate the inverse correlation between osteoclast survival and bone resorption. J. Biol. Chem., 2012, 287: 37808-37823

[201.] AgidigbiTS, KimC. Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-Mediated osteoclast diseases. Int. J. Mol. Sci., 2019, 20: 3576

[202.] WilliamsJP, et al. . Regulation of osteoclastic bone resorption by glucose. Biochem. Biophys. Res. Commun., 1997, 235: 646-651

[203.] IndoY, et al. . Metabolic regulation of osteoclast differentiation and function. J. Bone Miner. Res., 2013, 28: 2392-2399

[204.] AhnH, et al. . Accelerated lactate dehydrogenase activity potentiates osteoclastogenesis via NFATc1 signaling. PLoS One, 2016, 11: e0153886

[205.] SongC, et al. . Sexual dimorphism of osteoclast reliance on mitochondrial oxidation of energy substrates in the mouse. JCI Insight, 2023, 8: e174293

[206.] LucasS, et al. . Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat. Commun., 2018, 9

[207.] BrunnerJS, et al. . Environmental arginine controls multinuclear giant cell metabolism and formation. Nat. Commun., 2020, 11

[208.] ZengR, FaccioR, NovackDV. Alternative NF-kappaB Regulates RANKL-induced osteoclast differentiation and mitochondrial biogenesis via independent mechanisms. J. Bone Miner. Res., 2015, 30: 2287-2299

[209.] ZhangY, et al. . PGC1beta organizes the osteoclast cytoskeleton by mitochondrial biogenesis and activation. J. Bone Miner. Res., 2018, 33: 1114-1125

[210.] BaeS, et al. . MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRalpha. J. Clin. Investig., 2017, 127: 2555-2568

[211.] Marques-CarvalhoA, SardãoVA, KimHN, AlmeidaM. ECSIT is essential for RANKL-induced stimulation of mitochondria in osteoclasts and a target for the anti-osteoclastogenic effects of estrogens. Front. Endocrinol., 2023, 14

[212.] StegenS, MoermansK, StockmansI, ThienpontB, CarmelietG. The serine synthesis pathway drives osteoclast differentiation through epigenetic regulation of NFATc1 expression. Nat. Metab., 2024, 6: 141-152

[213.] LeeS, et al. . Glutamine metabolite alpha-ketoglutarate acts as an epigenetic co-factor to interfere with osteoclast differentiation. Bone, 2021, 145

[214.] JiX, et al. . Genetic activation of glycolysis in osteoblasts preserves bone mass in type I diabetes. Cell Chem. Biol., 2023, 30: 1053-1063.e1055

[215.] SongF, et al. . Osteoblast-intrinsic defect in glucose metabolism impairs bone formation in type II diabetic male mice. Elife, 2023, 12: e85714

[216.] FulzeleK, et al. . Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell, 2010, 142: 309-319

[217.] FerronM, et al. . Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell, 2010, 142: 296-308

[218.] DixitM, et al. . Skeletal response to insulin in the naturally occurring Type 1 diabetes mellitus mouse model. JBMR, 2021, 5

[219.] WeiJ, et al. . Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J. Clin. Investig., 2014, 124: 1-13

[220.] NapoliN, et al. . Mechanisms of diabetes mellitus-induced bone fragility. Nat. Rev. Endocrinol., 2017, 13: 208-219

[221.] Rios-ArceND, HumNR, LootsGG. Interactions between diabetes mellitus and osteoarthritis: from animal studies to clinical Data. JBMR, 2022, 6

[222.] NarendraDP, SteinhauserML. Metabolic analysis at the nanoscale with Multi-Isotope Imaging Mass Spectrometry (MIMS). Curr. Protoc. Cell Biol., 2020, 88

[223.] ZhaoY, et al. . In vivo monitoring of cellular energy metabolism using SoNar, a highly responsive sensor for NAD⁺/NADH redox state. Nat. Protoc., 2016, 11: 1345-1359

Funding

U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)(R01DK125498)